Nightstar Therapeutics Limited

/Nightstar Therapeutics Limited

They are a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness.

Symbol

Price Range
$13.00 - $15.00

Anticipated Shares
1,000,000

Anticipated Date
TBD

Underwriters

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange